New DTaP vaccine safety trial for children
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be in one of these age groups: 6 years old, 18-24 months old, or 2-3 months old.
- For 6-year-olds: must have already received 4 doses of the DTaP vaccine and not yet gotten the Td (tetanus-diphtheria) booster.
- For toddlers (18-24 months): must have received 3 doses of DTaP and 3 doses of polio vaccine, and not yet their booster doses.
- For infants (2-3 months): must never have received any DTaP, polio, or certain other vaccines (like Prevnar or Hib).
- Your child must be healthy, with no fever, no serious allergies to vaccines, and no history of seizures or brain disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
This study is checking how long the protection from an earlier vaccine (which combined protection against whooping cough, diphtheria, and tetanus) lasts. If you took part in that earlier trial, this follow-up will help see if you still have protection.
This study tests whether giving pregnant women a special tetanus, diphtheria, and pertussis vaccine (TdaP2gen) helps protect their babies from these diseases. Researchers will follow mothers and infants for up to 18 months to measure how well the vaccine works.
This trial tests a new vaccine (LR20062) to see how well it protects healthy babies against several diseases. Your baby would receive the vaccine at their 2-month, 4-month, and 6-month checkups.
Hear when a new Diphtheria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.